参考文献/References:
[1] Durgan DJ,Young ME. The cardiomyocyte circadian clock:emerging roles in health and disease[J]. Circ Res,2010,106(4):647-658.
[2] Carden DL,Granger DN. Pathophysiology of ischaemia-reperfusion injury[J]. J Pathol,2000,190(3):255-266.
[3] Mishra PK,Adameova A,Hill JA,et al. Guidelines for evaluating myocardial cell death[J]. Am J Physiol Heart Circ Physiol,2019,317(5):H891-H922.
[4] Zhang R,Lahens NF,Ballance HI,et al. A circadian gene expression atlas in mammals:implications for biology and medicine[J]. Proc Natl Acad Sci U S A,2014,111(45):16219-16224.
[5] Thosar SS,Butler MP,Shea SA. Role of the circadian system in cardiovascular disease[J]. J Clin Invest,2018,128(6):2157-2167.
[6] Lowrey PL,Takahashi JS. Genetics of circadian rhythms in Mammalian model organisms[J]. Adv Genet,2011,74:175-230.
[7] Martino T,Arab S,Straume M,et al. Day/night rhythms in gene expression of the normal murine heart[J]. J Mol Med(Berl),2004,82(4):256-264.
[8] Kung TA,Egbejimi O,Cui J,et al. Rapid attenuation of circadian clock gene oscillations in the rat heart following ischemia-reperfusion[J]. J Mol Cell Cardiol,2007,43(6):744-753.
[9] Bonney S,Kominsky D,Brodsky K,et al. Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart[J]. PLoS One,2013,8(8):e71493.
[10] Oyama Y,Bartman CM,Gile J,et al. The circadian PER2 enhancer nobiletin reverses the deleterious effects of midazolam in myocardial ischemia and reperfusion injury[J]. Curr Pharm Des,2018,24(28):3376-3383.
[11] Reitz CJ,Alibhai FJ,Khatua TN,et al. SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome[J]. Commun Biol,2019,2:353.
[12] Ghorbel MT,Coulson JM,Murphy D. Cross-talk between hypoxic and circadian pathways:cooperative roles for hypoxia-inducible factor 1alpha and CLOCK in transcriptional activation of the vasopressin gene[J]. Mol Cell Neurosci,2003,22(3):396-404.
[13] Wu Y,Tang D,Liu N,et al. Reciprocal regulation between the circadian clock and hypoxia signaling at the genome level in mammals[J]. Cell Metab,2017,25(1):73-85.
[14] Keller M,Mazuch J,Abraham U,et al. A circadian clock in macrophages controls inflammatory immune responses[J]. Proc Natl Acad Sci U S A,2009,106(50):21407-21412.
[15] Lee JH,Sancar A. Regulation of apoptosis by the circadian clock through NF-kappaB signaling[J]. Proc Natl Acad Sci U S A,2011,108(29):12036-12041.
[16] Mullenders J,Fabius AW,Madiredjo M,et al. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway[J]. PLoS One,2009,4(3):e4798.
[17] Wang EY,Gang H,Aviv Y,et al. p53 mediates autophagy and cell death by a mechanism contingent on Bnip3[J]. Hypertension,2013,62(1):70-77.
[18] Dhingra R,Margulets V,Chowdhury SR,et al. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling[J]. Proc Natl Acad Sci U S A,2014,111(51):E5537-E5544.
[19] Li E,Li X,Huang J,et al. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy[J]. Protein Cell,2020,11(9):661-679.
[20] Pacher P,Szabo C. Role of poly(ADP-ribose) polymerase 1(PARP-1) in cardiovascular diseases:the therapeutic potential of PARP inhibitors[J]. Cardiovasc Drug Rev,2007,25(3):235-260.
[21] Oerlemans MI,Liu J,Arslan F,et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo[J]. Basic Res Cardiol,2012,107(4):270.
[22] Ying L,Benjanuwattra J,Chattipakorn SC,et al. The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury[J]. Acta Physiol(Oxf),2021,231(2):e13541.
[23] McDonald MJ,Rosbash M. Microarray analysis and organization of circadian gene expression in Drosophila[J]. Cell,2001,107(5):567-578.
[24] Pfeifer U,Strauss P. Autophagic vacuoles in heart muscle and liver. A comparative morphometric study including circadian variations in meal-fed rats[J]. J Mol Cell Cardiol,1981,13(1):37-49.
[25] Rothermel BA,Hill JA. Myocyte autophagy in heart disease:friend or foe?[J]. Autophagy,2007,3(6):632-634.
[26] Sciarretta S,Hariharan N,Monden Y,et al. Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart?[J]. Pediatr Cardiol,2011,32(3):275-281.
[27] Wedel A,Ziegler-Heitbrock HW. The C/EBP family of transcription factors[J]. Immunobiology,1995,193(2-4):171-185.
[28] Lamia KA,Sachdeva UM,DiTacchio L,et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation[J]. Science,2009,326(5951):437-440.
[29] Egan DF,Shackelford DB,Mihaylova MM,et al. Phosphorylation of ULK1(hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy[J]. Science,2011,331(6016):456-461.
[30] Ishii T,Warabi E,Mann GE. Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis[J]. Free Radic Biol Med,2019,133:169-178.
[31] Liu J,Yang M,Kang R,et al. Autophagic degradation of the circadian clock regulator promotes ferroptosis[J]. Autophagy,2019,15(11):2033-2035.
[32] Gao M,Monian P,Quadri N,et al. Glutaminolysis and transferrin regulate ferroptosis[J]. Mol Cell,2015,59(2):298-308.
[33] Li W,Feng G,Gauthier JM,et al. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation[J]. J Clin Invest,2019,129(6):2293-2304.
[34] Fang X,Wang H,Han D,et al. Ferroptosis as a target for protection against cardiomyopathy[J]. Proc Natl Acad Sci U S A,2019,116(7):2672-2680.
[35] Ge X,Li W,Huang S,et al. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury[J]. Brain Res,2018,1697:10-20.
[36] Lacey CA,Mitchell WJ,Dadelahi AS,et al. Caspase-1 and caspase-11 mediate pyroptosis,inflammation,and control of brucella joint infection[J]. Infect Immun,2018,86(9):e00361-18.
[37] Afonina IS,Zhong Z,Karin M,et al. Limiting inflammation—The negative regulation of NF-κB and the NLRP3 inflammasome[J]. Nat Immunol,2017,18(8):861-869.
[38] Man SM,Karki R,Kanneganti TD. Molecular mechanisms and functions of pyroptosis,inflammatory caspases and inflammasomes in infectious diseases[J]. Immunol Rev,2017,277(1):61-75.
[39] Kayagaki N,Warming S,Lamkanfi M,et al. Non-canonical inflammasome activation targets caspase-11[J]. Nature,2011,479(7371):117-121.
[40] Kawaguchi M,Takahashi M,Hata T,et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury[J]. Circulation,2011,123(6):594-604.
[41] Pan J,Han L,Guo J,et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE-/- mice[J]. Biochem Biophys Res Commun,2018,498(3):487-494.
相似文献/References:
[1]罗富健 赵若楠.高血压时间治疗学的研究与展望[J].心血管病学进展,2019,(9):1237.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.013]
LUO Fujian ZHAO Ruonan.Chronotherapy of Hypertension[J].Advances in Cardiovascular Diseases,2019,(11):1237.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.013]
[2]彭可玲 贾晓艳 王华 刘永铭.铁死亡与心力衰竭的研究进展[J].心血管病学进展,2022,(5):432.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
PENG Keling,JIA Xiaoyan,WANG Hua,et al.Ferroptosis and Heart Failure[J].Advances in Cardiovascular Diseases,2022,(11):432.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
[3]胡睿杰 江洪.昼夜节律与心脏代谢研究进展[J].心血管病学进展,2023,(2):158.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.014]
HU Ruijie,JIANG Hong.Circadian Rhythm and Cardiac Metabolism[J].Advances in Cardiovascular Diseases,2023,(11):158.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.014]
[4]孙悦 付松波 李亦兰.心肌细胞铁死亡及其检测方法[J].心血管病学进展,2023,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.016]
SUN Yue,FU Songbo,LI Yilan.Methods for the Detection of Ferroptosis in Cardiomyocytes[J].Advances in Cardiovascular Diseases,2023,(11):167.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.016]
[5]陈艳华 孙慧.神经免疫心血管界面在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(10):911.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.011]
CHEN Yanhua,SUN Hui.Research Progress of Neuroimmune Cardiovascular Interfaces in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(11):911.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.011]
[6]张乐 邓嘉禾 马琳琳 宁忠平 李延飞.昼夜节律调节心律失常的机制及治疗药物的研究进展[J].心血管病学进展,2023,(12):1098.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.010]
ZHANG Le,DENG Jiahe,MA Linlin,et al.Mechanism and Therapeutic Drugs of?ircadian Rhythm Regulating Arrhythmia[J].Advances in Cardiovascular Diseases,2023,(11):1098.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.010]
[7]聂鹂庆 江洪.昼夜节律紊乱对急性心肌梗死的作用及机制的研究进展[J].心血管病学进展,2023,(12):1103.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.011]
NIE LiqingJIANG Hong.Effect and Mechanism of Circadian Rhythm Disturbance on Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2023,(11):1103.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.011]